BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

452 related articles for article (PubMed ID: 28057743)

  • 21. Stromal alterations in patients with monoclonal gammopathy of undetermined significance, smoldering myeloma, and multiple myeloma.
    Bogun L; Koch A; Scherer B; Fenk R; Maus U; Bormann F; Köhrer K; Petzsch P; Wachtmeister T; Zukovs R; Dietrich S; Haas R; Schroeder T; Jäger P; Geyh S
    Blood Adv; 2024 May; 8(10):2575-2588. PubMed ID: 38241490
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Upregulation of Syndecan-1 in the bone marrow microenvironment in multiple myeloma is associated with angiogenesis.
    Andersen NF; Kristensen IB; Preiss BS; Christensen JH; Abildgaard N
    Eur J Haematol; 2015 Sep; 95(3):211-7. PubMed ID: 25353275
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phenotypic and functional evaluations of peripheral blood monocytes from chronic-form paracoccidioidomycosis patients before and after treatment.
    Venturini J; Cavalcante RS; Golim Mde A; Marchetti CM; Azevedo PZ; Amorim BC; Arruda MS; Mendes RP
    BMC Infect Dis; 2014 Oct; 14():552. PubMed ID: 25314914
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The spectrum of somatic mutations in monoclonal gammopathy of undetermined significance indicates a less complex genomic landscape than that in multiple myeloma.
    Mikulasova A; Wardell CP; Murison A; Boyle EM; Jackson GH; Smetana J; Kufova Z; Pour L; Sandecka V; Almasi M; Vsianska P; Gregora E; Kuglik P; Hajek R; Davies FE; Morgan GJ; Walker BA
    Haematologica; 2017 Sep; 102(9):1617-1625. PubMed ID: 28550183
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytogenetic profiles in multiple myeloma and monoclonal gammopathy of undetermined significance: a study in highly purified aberrant plasma cells.
    Schmidt-Hieber M; Gutiérrez ML; Pérez-Andrés M; Paiva B; Rasillo A; Tabernero MD; Sayagués JM; Lopez A; Bárcena P; Sanchez ML; Gutiérrez NC; San Miguel JF; Orfao A
    Haematologica; 2013 Feb; 98(2):279-87. PubMed ID: 22929983
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Personalised progression prediction in patients with monoclonal gammopathy of undetermined significance or smouldering multiple myeloma (PANGEA): a retrospective, multicohort study.
    Cowan A; Ferrari F; Freeman SS; Redd R; El-Khoury H; Perry J; Patel V; Kaur P; Barr H; Lee DJ; Lightbody E; Downey K; Argyelan D; Theodorakakou F; Fotiou D; Liacos CI; Kanellias N; Chavda SJ; Ainley L; Sandecká V; Pospíšilová L; Minarik J; Jungova A; Radocha J; Spicka I; Nadeem O; Yong K; Hájek R; Kastritis E; Marinac CR; Dimopoulos MA; Get G; Trippa L; Ghobrial IM
    Lancet Haematol; 2023 Mar; 10(3):e203-e212. PubMed ID: 36858677
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Myeloma cell-osteoclast interaction enhances angiogenesis together with bone resorption: a role for vascular endothelial cell growth factor and osteopontin.
    Tanaka Y; Abe M; Hiasa M; Oda A; Amou H; Nakano A; Takeuchi K; Kitazoe K; Kido S; Inoue D; Moriyama K; Hashimoto T; Ozaki S; Matsumoto T
    Clin Cancer Res; 2007 Feb; 13(3):816-23. PubMed ID: 17289872
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adipose-derived mesenchymal stem cells modulate CD14
    Qiu G; Zheng G; Ge M; Huang L; Tong H; Chen P; Lai D; Hu Y; Cheng B; Shu Q; Xu J
    Stem Cell Res Ther; 2017 Apr; 8(1):97. PubMed ID: 28446249
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immature dendritic cells in multiple myeloma are prone to osteoclast-like differentiation through interleukin-17A stimulation.
    Tucci M; Stucci S; Savonarola A; Ciavarella S; Cafforio P; Dammacco F; Silvestris F
    Br J Haematol; 2013 Jun; 161(6):821-31. PubMed ID: 23594390
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Elevated CD14
    Zhang B; Qi X; Zhao Y; Li R; Zhang C; Chang HM; Pang Y; Qiao J
    Reprod Sci; 2018 Dec; 25(12):1629-1636. PubMed ID: 29439619
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An unbalanced PD-L1/CD86 ratio in CD14(++)CD16(+) monocytes is correlated with HCV viremia during chronic HCV infection.
    Zheng J; Liang H; Xu C; Xu Q; Zhang T; Shen T; Lu F
    Cell Mol Immunol; 2014 May; 11(3):294-304. PubMed ID: 24531620
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gene expression profiling of bone marrow endothelial cells in patients with multiple myeloma.
    Ria R; Todoerti K; Berardi S; Coluccia AM; De Luisi A; Mattioli M; Ronchetti D; Morabito F; Guarini A; Petrucci MT; Dammacco F; Ribatti D; Neri A; Vacca A
    Clin Cancer Res; 2009 Sep; 15(17):5369-78. PubMed ID: 19690192
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A HGF/cMET autocrine loop is operative in multiple myeloma bone marrow endothelial cells and may represent a novel therapeutic target.
    Ferrucci A; Moschetta M; Frassanito MA; Berardi S; Catacchio I; Ria R; Racanelli V; Caivano A; Solimando AG; Vergara D; Maffia M; Latorre D; Rizzello A; Zito A; Ditonno P; Maiorano E; Ribatti D; Vacca A
    Clin Cancer Res; 2014 Nov; 20(22):5796-807. PubMed ID: 25212607
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Contributions of the Bone Microenvironment to Monoclonal Gammopathy of Undetermined Significance Pathogenesis.
    Gámez B; Edwards CM
    Curr Osteoporos Rep; 2018 Dec; 16(6):635-641. PubMed ID: 30229522
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pathway-based network analysis of myeloma tumors: monoclonal gammopathy of unknown significance, smoldering multiple myeloma, and multiple myeloma.
    Dong L; Chen CY; Ning B; Xu DL; Gao JH; Wang LL; Yan SY; Cheng S
    Genet Mol Res; 2015 Aug; 14(3):9571-84. PubMed ID: 26345890
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CD16 (FcRgammaIII) as a potential marker of osteoclast precursors in psoriatic arthritis.
    Chiu YG; Shao T; Feng C; Mensah KA; Thullen M; Schwarz EM; Ritchlin CT
    Arthritis Res Ther; 2010; 12(1):R14. PubMed ID: 20102624
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gene Expression Analysis of the Bone Marrow Microenvironment Reveals Distinct Immunotypes in Smoldering Multiple Myeloma Associated to Progression to Symptomatic Disease.
    Isola I; Brasó-Maristany F; Moreno DF; Mena MP; Oliver-Calders A; Paré L; Rodríguez-Lobato LG; Martin-Antonio B; Cibeira MT; Bladé J; Rosiñol L; Prat A; Lozano E; Fernández de Larrea C
    Front Immunol; 2021; 12():792609. PubMed ID: 34880879
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatocyte growth factor pathway upregulation in the bone marrow microenvironment in multiple myeloma is associated with lytic bone disease.
    Kristensen IB; Christensen JH; Lyng MB; Møller MB; Pedersen L; Rasmussen LM; Ditzel HJ; Abildgaard N
    Br J Haematol; 2013 May; 161(3):373-82. PubMed ID: 23431957
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Maximal Exercise Alters the Inflammatory Phenotype and Response of Mononuclear Cells.
    Slusher AL; Zúñiga TM; Acevedo EO
    Med Sci Sports Exerc; 2018 Apr; 50(4):675-683. PubMed ID: 29112629
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Resveratrol inhibits myeloma cell growth, prevents osteoclast formation, and promotes osteoblast differentiation.
    Boissy P; Andersen TL; Abdallah BM; Kassem M; Plesner T; Delaissé JM
    Cancer Res; 2005 Nov; 65(21):9943-52. PubMed ID: 16267019
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.